ARTICLE | Financial News
Alkermes completes debt financing
May 16, 2011 7:00 AM UTC
Alkermes Inc. (NASDAQ:ALKS), Waltham, Mass. Business: Neurology, Endocrine, Autoimmune Date completed: 5/9/11 Type: Debt financing Raised: $450 million Investors: Morgan Stanley; HSBC Investment Bank ...